Martínez MLG, Pavón FN, Blanco LL, Macías GR, Castillo DL, Rosillo MJC, Coro GPY

Idioma: Español
Referencias bibliográficas: 27
Paginas: 225-231
Archivo PDF: 250.85 Kb.

RESUMEN

Estudio morfológico comparativo del trasplante dopaminérgico en diferentes ganglios basales el implante de un injerto de estuctura dopaminérgicas en ganglios basales es uno de los tratamientos del Parkinson. en este trabajo se presentan los resultados de este implante en el estriado los núcleos subtalámicos y en la sustancia negra, el estudio se efectuó en ratas wistar divididas en tres grupos. Se encontró que las células entranigrales e intrasubtalámicas a diferencia de las intraestructurales se difundian hacia varias áreas cercanas siendo el mayor crecimiento en los implantes en los núcleos subtalámicos y al parecer de caudado putamen ofrece el mejor medio para la sobrevivencia de las células dopaminérgicas.
of transplanted dopaminergic neurons intrastriatally thanthose transplanted into substantia nigra pars reticulataor the subthalamus and suggest that the caudate-putamen offers a more favorable cellular environmentfor the survival of dopaminergic cells than other testedstructures.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Brundin P, Barbin G, Strecker RE, Isacson O, Prochiantz A,Björklund A. Survival and function of dissociated rat dopamineneurones grafted at different developmental stages or afterbeing cultured in vitro. Brain Res 1988; 467(2): 233-43.

2. Mukhida K, Baker KA, Sadi D, Mendez I. Enhancement ofsensorimotor behavioral recovery in hemiparkinsonian rats withintrastriatal, intranigral, and intrasubthalamic nucleus dopa-minergic transplants. J Neurosci 2001; 21(10):3521-30.

3. Bartlett LE, Mendez I. Dopaminergic reinnervation of theglobus pallidus by fetal nigral grafts in the rodent model ofParkinson’s disease. Cell Transplant 2005;14(2-3):119-27.

4. Nikkhah G, Bentlage C, Cunningham MG, Björklund A.Intranigral fetal dopaminergic grafts induce behavioral com-pensation in the rat Parkinson model. J Neurosci 1994;14(6):3449-61.

5. Nikkhah G, Cunningham MG, Jödicke A, Knappe U, BjörklundA. Improved graft survival and striatal reinnervation using amicrotransplantation approach in the rat Parkinson model.Brain Res 1994;633:133-43.

6. Doucet G, Brundin P, Descarries L, Björklund A. Effect of priordopamine denervation on survival and fiber outgrowth fromintrastriatal fetal mesencephalic grafts. Eur J Neurosci 1990;2:279-90.

7. Hemmendinger LM, Garber BB, Hoffmann PC, Heller A.Target neuron specific process formation by embryonicmesencephalic dopamine neurons in vitro. PNAS 1981;78:1264-8.

8. Ostergaard K, Schou JP, Zimmer J. Rat ventral mesencephalongrown as organotipic slice cultures and co-cultured withstriatum, hippocampus, and cerebellum. Exp Brain Res1990;82:547-65.

9. Agrawal AK, Chaturvedi RK, Shukla S, Seth K, Chauhan S,Ahmad A, et al. Restorative potential of dopaminergic graftsin presence of antioxidants in rat model of Parkinson’s disease.J Chem Neuroanat 2004;28:253-64.

10. Lindvall O, Hagell P. Clinical observations after neuraltransplantation in Parkinson’s disease. Prog Brain Res 2000;127:299-320.

11. Nguyen JP. Neural transplantation for the treatment ofParkinson’s disease. Update and future. Neurochirurgic 2004;50:619-23.

12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates.2ed. New York: Academic Press; 1986.

13. Nikkhah G. Microtansplantation of nigral dopamine neurons ina rat model of Parkinson’ s disease. From the department ofMedical Cell Research. Sweden. Doctoral thesis: 1994.

14. Gundersen HJ, Jensen EB. The efficiency of systematicsampling in stereology and its prediction. J Microscopy1987;147:229-63.

15. Abercrombie M. Estimation of nuclear population frommicrotome sections. Anat Rec 1946; 94:239-46.

16. Pavón N, Macias González R, Blanco-Lezcano L, Alvárez-González L, Martínez- Martí L, Castillo L, et al. Efecto deltrasplante simultáneo de células mesencefálicas fetales en es-triado y en el núcleo subtalámico de ratas hemiparkinsonianas.Rev Neurol 2002;34(10):917-23.

17. Blanco L, Pavón N, Macías R, Castillo L, Díaz C, García A, etal. Microtrasplante simultáneo de células mesencefálicasfetales en estriado y substantia nigra pars reticulata de ratashemiparkinsonianas. Estudio conductual. Rev Neurol 2000; 30(12): 1122-7.

18. Carvey PM, Ptak LR, Lo ES, Lin D, Buhrfiend CM, Goetz CG,et al. Levodopa reduces the growth promoting effects ofstriatal extracts on rostral mesencephalic tegmentum culture.Exp Neurol 1991;114:28-34.

19. Prochiantz A, Daguet M, Herbet A, Glowinski J. Specificstimulation of in vitro maturation of mesencephalic dopami-nergic neurons by striatal membranes. Nature 1981; 293:570-2.

20. O´Malley E, Black I, Dreyfus C. Local support cells promotesurvival of substantia nigra dopaminergic neurons in culture.Exp Neurol 1991;112:40-8.

21. Brundin P, Strecker RE, Londos E, Björklund A. Dopamineneurons grafted unilaterally to the nucleus accumbens affectdrug-induced circling and locomotion. Exp Brain Res 1987;69:183-94.

22. Triarhou LC, Low LC, Ghetti B. Layer-specific innervation ofdopamine-deficient frontal cortex in weaver mutant mice bygrafted mesencephalic dopaminergic neurons. Cell Tiss Res1988;254:11-5.

23. Abrous N, Guy J, Vigny A, Calas A, Le Moal M, Herman JP.Development of intracerebral dopaminergic grafts: Acombined immunohistochemical and autoradiographic studyof its time course and environmental influences. J Comp Neurol1988;273:26-41.

24. Björklund A, Stenevi U, Schmidt RH, Dunnet SB, Gage FH.Intracerebral grafting of neuronal cell suspensions. II Survivaland growth of nigral cell suspensions implanted in differentbrain sites. Acta Physiol Scand 1983;522:9-18.

25. Abrous N, Guy J, Vigny A, Calas A, Le Moal M, Herman JP.Development of intracerebral dopaminergic grafts: Acombined immunohistochemical and autoradiographic studyof its time course and environmental influences. J Comp Neurol1988;273:26-41.

26. Nikkhah G, Olsson M, Eberhard J, Bentlage C, CunninghamMG, Björklund A. A microtrasplantation approach for cellsuspension grafting in the rat Parkinson model: A detailedaccount of the methodology. Neuroscience 1994;63 (1 ):57-72.

27. Bartlett LE, Sadi D, Lewington M, Mendez I. Functionalimprovement with low-dose dopaminergic grafts inhemiparkinsonian rats. Neurosurgery 2004;55(2):405-12;discussion 412-5.